PharmaRoth Labs Inc. (ROTH) Financials Nov 14, 201
Post# of 250675
Posted On: 11/17/2014 4:38:19 AM
PharmaRoth Labs Inc. (ROTH) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for PharmaRoth Labs Inc.
Fiscal year is July-June. All values USD millions. 2008 2009 2010 2013 2014 5-year trend
Sales/Revenue 0 0 0 153,892 529,047
Cost of Goods Sold (COGS) incl. D&A 0 0 0 119,666 212,629
COGS excluding D&A 0 0 0 117,553 212,169
Depreciation & Amortization Expense - 0 0 2,113 460
Depreciation - - 0 2,113 460
Amortization of Intangibles - - 0 0 0
Gross Income 0 0 0 34,226 316,418
2008 2009 2010 2013 2014 5-year trend
SG&A Expense 34,900 13,150 19,655 460,939 608,955
Research & Development 0 0 0 - -
Other SG&A 34,900 13,150 19,655 460,939 608,955
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 250,000 0 0
EBIT after Unusual Expense 0 0 (250,000) 0 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 0 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 0 0 0 - 0
Gross Interest Expense 0 0 0 - 0
Interest Capitalized 0 0 0 - 0
Pretax Income (34,900) (13,150) (269,655) (426,713) (292,537)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (34,900) (13,150) (269,655) (426,713) (292,537)
Minority Interest Expense 0 0 0 (1,515) (1,565)
Net Income (34,900) (13,150) (269,655) (425,198) (290,972)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (34,900) (13,150) (269,655) (425,198) (290,972)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (34,900) (13,150) (269,655) (425,198) (290,972)
EPS (Basic) () 0.00 0.00 () ()
Basic Shares Outstanding 127.5M 127.5M 46.74M 219.38M 280.69M
EPS (Diluted) () 0.00 0.00 () ()
Diluted Shares Outstanding 127.5M 127.5M 46.74M 219.38M 280.69M
EBITDA - (13,150) (19,655) (424,600) (292,077)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for PharmaRoth Labs Inc.
Fiscal year is July-June. All values USD millions. 2008 2009 2010 2013 2014 5-year trend
Sales/Revenue 0 0 0 153,892 529,047
Cost of Goods Sold (COGS) incl. D&A 0 0 0 119,666 212,629
COGS excluding D&A 0 0 0 117,553 212,169
Depreciation & Amortization Expense - 0 0 2,113 460
Depreciation - - 0 2,113 460
Amortization of Intangibles - - 0 0 0
Gross Income 0 0 0 34,226 316,418
2008 2009 2010 2013 2014 5-year trend
SG&A Expense 34,900 13,150 19,655 460,939 608,955
Research & Development 0 0 0 - -
Other SG&A 34,900 13,150 19,655 460,939 608,955
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 250,000 0 0
EBIT after Unusual Expense 0 0 (250,000) 0 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 0 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 0 0 0 - 0
Gross Interest Expense 0 0 0 - 0
Interest Capitalized 0 0 0 - 0
Pretax Income (34,900) (13,150) (269,655) (426,713) (292,537)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (34,900) (13,150) (269,655) (426,713) (292,537)
Minority Interest Expense 0 0 0 (1,515) (1,565)
Net Income (34,900) (13,150) (269,655) (425,198) (290,972)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (34,900) (13,150) (269,655) (425,198) (290,972)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (34,900) (13,150) (269,655) (425,198) (290,972)
EPS (Basic) () 0.00 0.00 () ()
Basic Shares Outstanding 127.5M 127.5M 46.74M 219.38M 280.69M
EPS (Diluted) () 0.00 0.00 () ()
Diluted Shares Outstanding 127.5M 127.5M 46.74M 219.38M 280.69M
EBITDA - (13,150) (19,655) (424,600) (292,077)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)